“We are enthusiastic about getting patients started in the OCU200 Phase 1 clinical trial and sharing not only safety but preliminary efficacy data as the study progresses,” said Dr. Huma Qamar, Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback